Back to Browse Journals » Vascular Health and Risk Management » Volume 5

Prognostic stratification of acute pulmonary embolism: Focus on clinical aspects, imaging, and biomarkers

Authors Luca Masotti, Marc Righini, Nicolas Vuilleumier, Fabio Antonelli, et al.

Published 2 July 2009 Volume 2009:5 Pages 567—575


Review by Single-blind

Peer reviewer comments 3

Luca Masotti1, Marc Righini2, Nicolas Vuilleumier3, Fabio Antonelli4, Giancarlo Landini5, Roberto Cappelli6, Patrick Ray7

1Internal Medicine, 4Clinical Chemistry, Cecina Hospital, Cecina, Italy; 2Division of Angiology and Haemostasis, Department of Internal Medicine, Geneva University Hospital, Switzerland; 3Division of Laboratory Medicine, Department of Genetics and Laboratory Medicine, Geneva University Hospitals and University of Geneva, Switzerland; 5Internal Medicine, Santa Maria Nuova Hospital, Florence, Italy; 6Thrombosis Center, University of Siena, Siena, Italy; 7Department of Emergency Medicine, Centre Hospitalo-Universitaire Pitié-Salpêtrière, UPMC Paris 6, Paris, France

Abstract: Pulmonary embolism (PE) represents a common disease in emergency medicine and guidelines for diagnosis and treatment have had wide diffusion. However, PE morbidity and mortality remain high, especially when associated to hemodynamic instability or right ventricular dysfunction. Prognostic stratification to identify high risk patients needing to receive more aggressive pharmacological and closer monitoring is of utmost importance. Modern guidelines for management of acute PE are based on risk stratification using either clinical, radiological, or laboratory findings. This article reviews the modern treatment of acute PE, which is customized upon patient prognosis. Accordingly the current risk stratification tools described in the literature such as clinical scores, echocardiography, helical computer tomography, and biomarkers will be reviewed.

Keywords: pulmonary embolism, prognosis, troponin, BNP, NT-proBNP, echocardiography, computer tomography

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Other article by this author:

Pulmonary embolism in the elderly: a review on clinical, instrumental and laboratory presentation

Luca Masotti, Patrick Ray, Marc Righini, Gregoire Le Gal, Fabio Antonelli, et al

Vascular Health and Risk Management 2008, 4:629-636

Published Date: 6 June 2008

Readers of this article also read:

Preparation, characterization, and in vivo pharmacokinetics of nanostructured lipid carriers loaded with oleanolic acid and gentiopicrin

Zhang KC, Lv SW, Li XY, Feng YF, Li X, Liu L, Li S, Li YJ

International Journal of Nanomedicine 2013, 8:3227-3239

Published Date: 22 August 2013

Evaluation of in vitro glistening formation in hydrophobic acrylic intraocular lenses

Thomes BE, Callaghan TA

Clinical Ophthalmology 2013, 7:1529-1534

Published Date: 25 July 2013

Effects of tafluprost treatment for 3 years in patients with normal-tension glaucoma

Inoue K, Tanaka A, Tomita G

Clinical Ophthalmology 2013, 7:1411-1416

Published Date: 9 July 2013

Comparison of ultra-widefield fluorescein angiography with the Heidelberg Spectralis® noncontact ultra-widefield module versus the Optos® Optomap®

Witmer MT, Parlitsis G, Patel S, Kiss S

Clinical Ophthalmology 2013, 7:389-394

Published Date: 21 February 2013


De Caterina AR, Harper AR, Cuculi F

Vascular Health and Risk Management 2012, 8:443-445

Published Date: 19 July 2012

The etiological features of anterior uveitis in a Turkish population

Guney E, Sezgin Akcay BI, Erdogan G, Unlu C, Akcali G, Bayramlar H

Clinical Ophthalmology 2012, 6:845-849

Published Date: 1 June 2012

Pharmacokinetics of intravitreal bevacizumab (Avastin®) in rabbits

Sinapis C, Routsias JG, Sinapis A, Sinapis D, Agrogiannis G, Pantopoulou A, Theocharis SE, Baltatzis S, Patsouris E, Perrea DN

Clinical Ophthalmology 2011, 5:697-704

Published Date: 24 May 2011

Construction of random perfect phylogeny matrix

Mehdi Sadeghi, Hamid Pezeshk, Changiz Eslahchi, et al

Advances and Applications in Bioinformatics and Chemistry 2010, 3:89-96

Published Date: 16 November 2010

Efficacy and safety of travoprost/timolol vs dorzolamide/timolol in patients with open-angle glaucoma or ocular hypertension

Miguel A Teus, Stefano Miglior, Guna Laganovska, et al

Clinical Ophthalmology 2009, 3:629-636

Published Date: 13 November 2009